MD
Therapeutic Areas
Panbela Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ivospemin (SBP-101) | Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 |
| Flynpovi™ (CPP-1X/sulindac) | Familial Adenomatous Polyposis (FAP) | Phase 3 |
| SBP-101 (Ivospemin) | Other Solid Tumors | Research |